TaiwanBiotech Take-Off Plan and new rules

This is an Insight article, written by a selected partner as part of IAM's co-published content. Read more on Insight

Taiwan’s Executive Yuan announced its Biotech Take- Off Diamond Plan in 2009. The strategic plan is designed to strengthen trust in the infrastructure of IP protection through world-class expertise in integrating electronics and semiconductors, and to transform Taiwan into a regional hub for biotech research and development (R&D), manufacturing and operations. This strategic plan aims to provide an efficient mechanism to ease the transition between research and pre-clinical development for new drugs and medical devices. Under the plan, a biotech venture capital fund of $1.76 billion, the so-called ‘mega fund’, has been established for start-ups. In addition, several changes have been made to IP regulations and infrastructures in Taiwan in order to ensure good IP practice in Taiwan, especially in the field of biotechnology.


Unlock unlimited access to all IAM content